U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07088822) titled 'A Phase 1 Study Evaluating the Safety, Tolerability, and Immunogenicity of V4020 Vaccine in Healthy Volunteers' on July 19.
Brief Summary: The purpose of the study is to evaluate the safety and immunogenicity of a novel Venezuelan Equine Encephalitis virus (VEEV) vaccine (V4020) for the first time in humans compared to placebo when administered by subcutaneous or intramuscular injection.
Study Start Date: Aug. 15
Study Type: INTERVENTIONAL
Condition:
Venezuelan Equine Encephalitis
Venezuelan Equine Encephalitis Virus Infection
Intervention:
BIOLOGICAL: V4020
The V4020 vaccine was prepared using an iDNA(R) infectious clone tha...